Cerebellar Ataxia: Clinical Trials

202 trials for Cerebellar Ataxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 42 unknown, 26 recruiting, 16 active not recruiting. 87 Not applicable, 32 Phase 2, 18 Phase 3, 14 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable87Completed 40, Unknown 21, Recruiting 13, Active not recruiting 5, Not yet recruiting 4, Withdrawn 3, Terminated 1
Phase 232Completed 19, Recruiting 3, Unknown 3, Not yet recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1
Phase 318Completed 10, Terminated 4, Active not recruiting 3, Recruiting 1
Phase 114Completed 4, Unknown 4, Recruiting 3, Terminated 2, Active not recruiting 1
Phase 43Completed 2, Unknown 1
Early Phase 11Completed 1

Follow Cerebellar Ataxia: new trials by email Literature Review of Cerebellar Ataxia trials Research Report on Cerebellar Ataxia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia
Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
Phase 2Not yet recruitingSclnow Biotechnology Co., Ltd.452026-12-312026-04-23
Multi-Modal Digital Monitoring of Disease Symptoms in Spinocerebellar Ataxia
Spinocerebellar Ataxia (SCA)
Not yet recruitingBioSensics252026-12-152026-10-01
Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Motor Neuron Diseases, Spinocerebellar Ataxias
RecruitingFirst Affiliated Hospital of Wannan Medical College1802026-09-302026-10-23
Biomarkers for Babies and Young Children With Ataxia Telangiectasia
Ataxia Telangiectasia
Not yet recruitingUniversity of Nottingham562026-09-012026-07-16
Pivotal Study of N-acetyl-L-leucine for CACNA1A
N-Acetyl-L-Leucine, Placebo - CACNA1A, Spinocerebellar Ataxia Type 6
Phase 3RecruitingIntraBio Inc602026-08-172026-09-08
Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3
Transcranial Temporal Interference Stimulation (tTIS) - Spinocerebellar Ataxia Type 3
Not applicableNot yet recruitingFirst Affiliated Hospital of Fujian Medical University242026-08-072026-09-01
Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)
Antisense oligonucleotide targeting the ATM gene - Ataxia Telangiectasia
Phase 1 / Phase 2RecruitingTimothy Yu102026-08-012026-05-28
Individualized Neuro-Modulation Paired With Cerebellar Therapy
Therapy - Cerebellar Ataxia, Cerebellar Diseases
Not applicableRecruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.302026-06-302026-06-11
Interposed Nucleus aDBS for Ataxia
Deep Brain Stimulation - Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
Not applicableRecruitingUniversity of Florida52026-06-022026-07-20
Deep Brain Stimulation for Spinocerebellar Ataxia
Deep Brain Stimulation (DBS) - Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
Not applicableRecruitingUniversity of California, San Francisco52026-04-272026-07-13
At Home Use of Stimulation Suits for Managing MS Symptoms
electro-stimulation suit, Usual Care - Multiple Sclerosis, MS (Multiple Sclerosis)
Not applicableRecruitingDaphne Kos702026-03-162026-10-08
Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxia
Aerobic Training, Balance Training - Spinocerebellar Ataxias
Not applicableWithdrawnColumbia University2026-01-012026-05-07
Autosomal Dominant Spinocerebellar Ataxias and Social Cognition
tests - Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)
Not applicableRecruitingUniversity Hospital, Angers1602025-12-092026-07-20
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg - Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 1 / Phase 2RecruitingBeijing Tide Pharmaceutical Co., Ltd2662025-12-032026-01-28
Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias
Neurological assessment, Ophthalmological assessment - Spinocerebellar Ataxia
Not applicableRecruitingUniversity Hospital, Montpellier602025-10-102025-11-20
rTMS for Cerebellar Ataxia in Children
Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation - Cerebellar Ataxia
Not applicableNot yet recruitingThe University of Hong Kong202025-10-012025-10-08
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
New Scale to evaluate ataxia motor symptoms - Ataxia, Cerebellar, Ataxia, Gait
Not yet recruitingHaute Ecole de Santé Vaud642025-09-012025-08-13
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
Stemchymal, Placebo - Spinocerebellar Ataxias
Phase 2Not yet recruitingSteminent US, Inc.202025-06-012024-05-02
Evaluation of Urinary Dysfunction in CANVAS Patients
Evaluation of urinary dysfunction in patients with CANVAS - Cerebellar Ataxia, Neuropathy
Not applicableRecruitingCentre Hospitalier Universitaire de Nice402025-03-212025-03-26
Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias
navigated iTBS (Intermittent theta-burst stimulation) targeting the cerebellum - Spinocerebellar Ataxias
Not applicableNot yet recruitingXijing Hospital802025-03-202025-03-27

Showing 20 of 202. Sign in to see all of them.

Narrower conditions

Spinocerebellar Ataxias (92)  ·  Ataxia Telangiectasia (42)  ·  Ataxia (36)  ·  Machado-Joseph Disease (32)  ·  Spinocerebellar Degenerations (17)  ·  Multiple System Atrophy (9)  ·  Neurodegenerative Diseases (9)  ·  Motor Activity (7)  ·  Cerebellar Diseases (6)  ·  Gait Ataxia (6)  ·  Huntington Disease (6)  ·  Parkinson Disease (6)  ·  Genetic Diseases, Inborn (5)  ·  Friedreich Ataxia (4)

Broader conditions

Brain Diseases (201)  ·  Central Nervous System Diseases (201)  ·  Dyskinesias (201)  ·  Neurologic Manifestations (201)  ·  Nervous System Diseases (200)  ·  Cerebellar Diseases (196)  ·  Ataxia (166)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (158)  ·  Genetic Diseases, Inborn (152)  ·  Heredodegenerative Disorders, Nervous System (118)  ·  Neurodegenerative Diseases (115)  ·  Spinal Cord Diseases (115)  ·  Pathological Conditions, Signs and Symptoms (101)  ·  Spinocerebellar Degenerations (96)

Interventions

Transcranial Magnetic Stimulation (7)  ·  Blood Specimen Collection (5)  ·  Transcranial Direct Current Stimulation (5)  ·  acetylleucine (4)  ·  Deep Brain Stimulation (3)  ·  Immunoglobulins, Intravenous (3)  ·  Lithium Carbonate (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Riluzole (3)  ·  nicotinamide-beta-riboside (3)  ·  Heptavalent Pneumococcal Conjugate Vaccine (2)  ·  IB1001 (2)  ·  Magnetic Resonance Imaging (2)  ·  Specimen Handling (2)  ·  Spinal Puncture (2)

Sponsors

Johann Wolfgang Goethe University Hospital (6)  ·  Chang Gung University (5)  ·  Columbia University (5)  ·  Hospital de Clinicas de Porto Alegre (5)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (5)  ·  Institut National de la Santé Et de la Recherche Médicale, France (4)  ·  IntraBio Inc (4)  ·  Johns Hopkins University (4)  ·  Kissei Pharmaceutical Co., Ltd. (4)  ·  Quince Therapeutics S.p.A. (4)  ·  University of Florida (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (3)  ·  Biohaven Pharmaceuticals, Inc. (3)  ·  Changhua Christian Hospital (3)

Countries

United States (66)  ·  France (22)  ·  Germany (18)  ·  Italy (18)  ·  United Kingdom (18)  ·  Spain (13)  ·  Brazil (12)  ·  Israel (12)  ·  Taiwan (12)  ·  China (10)  ·  Belgium (6)  ·  Netherlands (6)  ·  Switzerland (6)  ·  Australia (5)  ·  Canada (5)

Top investigators

Stefan Zielen, Prof. Dr. (5)  ·  Theresa Zesiewicz, MD (4)  ·  Alberto Benussi, MD (3)  ·  Amy J Bastian, PhD, PT (3)  ·  Barbara Borroni, MD (3)  ·  Carlos Gordon, Prof. (2)  ·  Cherie Marvel, PhD (2)  ·  David Coman, MBBS FRACP (2)  ·  Didier Hannequin, MD, PhD (2)  ·  Dirk Thye, MD (2)  ·  Jean-Philippe Azulay, MD, PhD (2)  ·  Laura B. Jardim, MD, PhD (2)  ·  Patrick Calvas, MD, PhD (2)

Results publications

PMID 15313841, PMID 15365159, PMID 16193476, PMID 24780882, PMID 30135258, PMID 34115419, PMID 34477998, PMID 40739200, PMID 12925365, PMID 12925368, PMID 14506070, PMID 14705117, PMID 14736755, PMID 14770181, PMID 15574463, PMID 15596607, PMID 15747371, PMID 15786464, PMID 15895558, PMID 15895562, PMID 15956167, PMID 16055926, PMID 16325416, PMID 16401858, PMID 16434418, PMID 16501573, PMID 16511635, PMID 16518257, PMID 16534102, PMID 16612642, PMID 16682547, PMID 16699786, PMID 16763896, PMID 16934683, PMID 17098887, PMID 17130408, PMID 17205300, PMID 17273843, PMID 17321752, PMID 17322883, PMID 17344386, PMID 17503452, PMID 17515546, PMID 17597328, PMID 17605047, PMID 17957230, PMID 18079167, PMID 18098276, PMID 18332254, PMID 18378516

NIH funding

2018 (2), 2025 (2), R01HD040289 (2), 2015 (1), 2017 (1), K23NS121518 (1), P2CHD086844 (1), R01DC016275 (1), R01DC017091 (1), R21AG044449 (1), R21NS085491 (1), R21NS094946 (1), R21NS125546 (1), U01NS106670 (1)